Membrane fluidity is a critical parameter of cellular membranes which cells continuously strive to maintain within a viable range. An interference with the correct membrane fluidity state can strongly inhibit cell function. Triggered changes in membrane fluidity have been postulated to contribute to the mechanism of action of membrane targeting antimicrobials, but the corresponding analyses have been hampered by the absence of readily available analytical tools. Here, we provide detailed protocols that allow straightforward measurement of antibiotic compound-triggered changes in membrane fluidity both in vivo and in vitro.
Epand RM, Epand RF (2009) Lipid domains in bacterial membranes and the action of antimicrobial agents. Biochim Biophys Acta 1788:289–294CrossRefPubMedGoogle Scholar
Parasassi T, De Stasio G, Ravagnan G, Rusch RM, Gratton E (1991) Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence. Biophys J 60:179–189CrossRefPubMedPubMedCentralGoogle Scholar
Chico DE, Given RL, Miller BT (2003) Binding of cationic cell-permeable peptides to plastic and glass. Peptides 24:3–9CrossRefPubMedGoogle Scholar
New RRC (1990) Liposomes: a practical approach. IRL Press, OxfordGoogle Scholar
Ingram LO (1977) Changes in lipid composition of Escherichia coli resulting from growth with organic solvents and with food additives. Appl Environ Microbiol 33:1233–1236PubMedPubMedCentralGoogle Scholar